targeted drug
Phase 3Small molecule
targeted drug is one of 51 small molecule programs targeting Chemotherapy. It is currently in Phase 3.
1
Indications
1
Total Trials
1
Active Trials
50
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
116 competitors in Chemotherapy
#DrugCompanyPhaseTrials
1Taxol
TevaPhase 3
Eloxatin
TevaPhase 3
Platinol
MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Phase 3
Avastin
RochePhase 3
Cytosar
TevaPhase 3
Imfinzi
AstraZenecaPhase 3
Camptosar
PfizerPhase 3
Vepesid
AAvyxa
Phase 3
Opdivo
Bristol-Myers SquibbPhase 3
Beyfortus
BeiGenePhase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for targeted drug. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details